Fig. 1 · Structure
Documents & Downloads
G0-C14 analog
G0-C14 Derivative
G0-C14 analog is a derivative of G0-C14, an ionizable cationic lipid. This compound is utilized in synthesizing lipid nanoparticles (LNP), which are critical for drug delivery applications, particularly in mRNA therapeutics and gene editing. Its ability to form stable nanoparticles enhances the efficacy of nucleic acid therapeutics, making it a valuable tool for researchers in the fields of drug development and molecular biology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2935435-86-0 |
| Applications | G0-C14 Derivative |
| Formula | C134H272N10O12 |
| Molecular Weight | 2215.65 |
| SMILES | O=C(NCCN(CC(CCCCCCCCCCCC)O)CC(O)CCCCCCCCCCCC)CCN(CCN(CCC(NCCN(CC(CCCCCCCCCCCC)O)CC(O)CCCCCCCCCCCC)=O)CCC(NCCN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)=O)CCC(NCCN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.